Template:Ergolines: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import |
en>AlyInWikiWonderland Add 13-fluorolysergol. |
||
| Line 8: | Line 8: | ||
| list1 = | | list1 = | ||
* [[2-Bromo-LSD|2-Bromo-LSD (BOL-148)]] | * [[2-Bromo-LSD|2-Bromo-LSD (BOL-148)]] | ||
* [[13-Fluorolysergol]] | |||
* [[Amesergide]] | |||
* [[Bromerguride|Bromerguride (2-bromolisuride)]] | |||
* [[Bromocriptine]] | * [[Bromocriptine]] | ||
* [[Cabergoline]] | * [[Cabergoline]] | ||
| Line 24: | Line 27: | ||
* [[Ergometrine]] (Ergonovine, Ergobasine) | * [[Ergometrine]] (Ergonovine, Ergobasine) | ||
* [[Ergometrinine]] | * [[Ergometrinine]] | ||
* [[Ergostine]] | |||
* [[Ergotamine]] | * [[Ergotamine]] | ||
* [[Ergotoxine]] | * [[Ergotoxine]] | ||
* [[Ergovaline]] | * [[Ergovaline]] | ||
* [[Fludihydroergotamine]] | |||
* [[Lisuride]] | * [[Lisuride]] | ||
* [[LY-215,840]] | * [[LY-215,840]] | ||
* [[Lysergic acid hydroxyethylamide|LSH]] | * [[Lysergic acid hydroxyethylamide|LSH]] | ||
* [[Lysergic acid | * [[Lysergic acid]] | ||
* [[Lysergic acid methyl ester | * [[Lysergic acid methyl ester]] | ||
* [[Lysergine]] | |||
* [[Lysergol]] | * [[Lysergol]] | ||
* [[Mergocriptine]] | |||
* [[Mesulergine]] | * [[Mesulergine]] | ||
* [[Metergoline]] | * [[Metergoline]] | ||
* [[ | * [[Metergotamine]] | ||
* [[Methylisopropyllysergamide|MIPLA]] | |||
* [[Methysergide]] | * [[Methysergide]] | ||
* [[Propisergide]] | |||
* [[Sergolexole]] | * [[Sergolexole]] | ||
| group2 = [[Psychedelic drug|Psychedelic]]<br/> [[lysergamides]] | | group2 = [[Psychedelic drug|Psychedelic]]<br/> [[lysergamides]] | ||
| Line 50: | Line 58: | ||
* [[BU-LAD]] | * [[BU-LAD]] | ||
* [[CYP-LAD]] | * [[CYP-LAD]] | ||
* [[ | * [[Diallyllysergamide]] (DAL) | ||
* [[DAM-57 | * [[Dimethyllysergamide]] (DAM-57) | ||
* [[ECPLA]]<!-- In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures.'' In: ''Analytical and Bioanalytical Chemistry.'' 2019, {{DOI|10.1007/s00216-018-1558-9}}. --> | * [[ECPLA]]<!-- In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures.'' In: ''Analytical and Bioanalytical Chemistry.'' 2019, {{DOI|10.1007/s00216-018-1558-9}}. --> | ||
* [[Ergonovine]] | * [[Ergonovine]] | ||
| Line 59: | Line 67: | ||
* [[LAMPA]]<!-- Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA) doi: 10.1007/s00213-018-5055-9 --> | * [[LAMPA]]<!-- Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA) doi: 10.1007/s00213-018-5055-9 --> | ||
* [[LAE-32]] | * [[LAE-32]] | ||
* [[LSD]] | * [[LSD|LSD (lysergide)]] | ||
* [[LPD-824]] | * [[LPD-824]] | ||
* [[LSM-775]] | * [[LSM-775]] | ||
| Line 69: | Line 77: | ||
* [[Lysergic acid cyclobutylamide]] | * [[Lysergic acid cyclobutylamide]] | ||
* [[Lysergic acid cyclopentylamide]] | * [[Lysergic acid cyclopentylamide]] | ||
* [[ | * [[Methylergometrine]] (Methylergonovine, Methylergobasine) | ||
* [[Methylisopropyllysergamide|MIPLA]] | * [[Methylisopropyllysergamide|MIPLA]] | ||
* [[MLD-41]] | * [[MLD-41]] | ||
| Line 75: | Line 83: | ||
* [[PRO-LAD]] | * [[PRO-LAD]] | ||
| group3 = | | group3 = [[Clavine]]s | ||
| list3 = | | list3 = | ||
* [[9-Deacetoxyfumigaclavine C]] | |||
* [[Agroclavine]] | * [[Agroclavine]] | ||
* [[Chanoclavine]] | |||
* [[Chanoclavine II]] | |||
* [[Costaclavin]] | |||
* [[Cycloclavine]] | |||
* [[Elymoclavine]] | * [[Elymoclavine]] | ||
* [[Epoxyagroclavine]] | |||
* [[Festuclavine]] | * [[Festuclavine]] | ||
* [[Fumigaclavine A]] | * [[Fumigaclavine A]] | ||
* [[Fumigaclavine B]] | * [[Fumigaclavine B]] | ||
* [[Fumigaclavine C]] | * [[Fumigaclavine C]] | ||
* [[Paliclavine]] | |||
* [[Penniclavine]] | |||
* [[Setoclavine]] | |||
| group4 = Other<br/> ergolines | | group4 = Other<br/> ergolines | ||
| list4 = | | list4 = | ||
* [[Acetergamine]] | |||
* [[Brazergoline]] | |||
* [[Cianergoline]] | |||
* [[CY-208,243]] | |||
* [[Delergotrile]] | |||
* [[Descarboxylysergic acid]] | |||
* [[Disulergine]] | |||
* [[Dosergoside]] | |||
* [[Ergoline]] | * [[Ergoline]] | ||
* [[Etisulergine]] | |||
* [[Lergotrile]] | * [[Lergotrile]] | ||
* [[Nicergoline]] | |||
* [[Pergolide]] | * [[Pergolide]] | ||
* [[Proterguride]] | |||
* [[Romergoline]] | |||
* [[Terguride]] | |||
* [[Tiomergine]] | |||
* [[Voxergolide]] | |||
| group5 = | | group5 = Related<br /> compounds | ||
| list5 = | | list5 = | ||
* [[Adrogolide]] | |||
* [[Naxagolide]] | |||
* [[Quinagolide]] | |||
| group6 = Natural<br/> sources | |||
| list6 = | |||
* ''[[Achnatherum robustum]]'' (Sleepy Grass) | * ''[[Achnatherum robustum]]'' (Sleepy Grass) | ||
* [[Claviceps|''Claviceps'' spp.]] (Ergot)<br /> | * [[Claviceps|''Claviceps'' spp.]] (Ergot)<br /> | ||
| Line 98: | Line 136: | ||
}}<noinclude> | }}<noinclude> | ||
{{collapsible option}} | {{collapsible option}} | ||
[[Category:Drug templates by structure]] | |||
[[Category:Ergolines|!]] | |||
</noinclude> | </noinclude> | ||
